FUJIFILM ANNOUNCES NEW DR-BASED FFDM SYSTEM

Delivers best DR resolution available with potential for reduced dose

  

Chicago, IL - November 30, 2008 - FUJIFILM Medical Systems USA, Inc., the worldwide leader in Full Field Digital Mammography (FFDM), is pleased to announce its first DR-based FFDM system1. Based on advanced dual layer amorphous selenium (a-Se) DR detector technology and an innovative direct conversion method, the new system will provide exceptional image quality while also offering the opportunity for reduced dose and enhanced workflow efficiency.

Using a unique combination of technologies, Fujifilm’s DR-based FFDM system will not only provide enhanced image quality but also increased efficiency. Its 50 micron resolution is currently the best resolution for DR-based FFDM imaging and also the world’s smallest pixel pitch for an amorphous selenium direct conversion method. Using direct optical switching (DOS) technology, image quality is further enhanced with a high signal to noise (S/N) ratio and the highest DQE (detective quantum efficiency) for clearer images with the potential for reduced dose. The DOS also improves workflow by shortening the image capture cycle time, making it most efficient direct conversion flat panel detector to date.

“We’re thrilled to be introducing such an innovative DR-based FFDM system. Its unprecedented image resolution will provide facilities with the confidence they need for the detailed visualization that’s required in mammography,” stated Jeanine Rader, Fujifilm’s Director of Women’s Healthcare. “And when added to Fujifilm’s complete lineup of versatile, scalable solutions for acquiring, processing and managing digital data, Fujifilm’s DR-based FFDM system will further increase efficiency, improve productivity and deliver the lowest cost of ownership available.”

The introduction of this FFDM system will make Fujifilm the first women’s health care company to offer both DR and CR FFDM solutions. Already the world leader in FFDM with more than 6,000 systems sold, Fujifilm is poised to now strengthen this leadership position with a choice of high quality FFDM imaging solutions to best meet the specific needs of any breast screening facility, regardless of size or imaging requirements.

Known as the AMULET in countries outside of the U.S., the 18x24cm detector version of Fujifilm’s DR-based FFDM system was recently released for sale in Japan. The availability of the AMULET with a 24x30cm detector is anticipated shortly. While plans for a U.S. launch of the product are not yet finalized, when this system completes the FDA approval process it will be sold in the U.S. under the Aspire brand of breast imaging products.

About FUJIFILM Medical Systems USA, Inc.
As one of the FUJIFILM Corporation family of companies with 70 years of imaging experience and more than $28 billion in sales, FUJIFILM Medical Systems USA, Inc. is a leading provider of diagnostic imaging products and network systems to meet the needs of healthcare facilities today and well into the future. Fujifilm’s Synapse® PACS (picture archiving and communications system) provides a seamless solution for managing, storing and distributing images and information throughout the entire healthcare enterprise. Its Web integrated design and hardware-independence provide a technological infrastructure and deployment model that can be expanded upon in a myriad of ways to adapt to evolving technologies. FUJIFILM Medical Systems USA is headquartered in Stamford, CT.

1 This product is under development and is not commercially available in the U.S.